The use of entacapone in patients with advanced Parkinson's disease: 2 years' experience

Neurological Sciences

Volumn 24, Issue 3, 2003, Pages 197-198

  Paci, C ^a   Sanguigni, S ^a   Carboni, T ^a   Gobbato, R ^a   Curatola, L ^a  

^a Madonna del Soccorso Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSKINESIA; HUMAN; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; NAUSEA; PARKINSON DISEASE; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTIPARKINSON AGENTS; CATECHOLS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0142248480     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0128-9     Document Type: Article

References (6)

1. Hornykiewicz O (1982) Brain neurotransimtter changes in Parkinson's disease. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth, London, pp 41-58
2. Rinne UK, Larsen JP, Siden A, Worm-Petersen J, and the NONECOMT Study Group (1998) Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Neurology 51:1309-1314
3. Myllyla VV, Kultalahati ER, Haapaniemi H, Leinonen M, and the FILOMEN Study Group (2001) Twelve-month safety of entacapone in patients with Parkinson'd disease. Eur J Neurol 8:53-60
4. Mannista PT, Kaakkola S (1990) Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. Phamarcol. Toxicol 66:317-323
5. Keranen T, Gordin A, Hariola VP et al (1993) The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers. Clin Neurophamacol 16:145-156
6. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, vol. 2. Mcmillan Health Care Information, Florham Park, NJ, pp 153-164